CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Sygnis Bioscience GmbH & Co KG

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2009

Acquired by Expedeon on Jun 26, 2017

Timeline

1990s

Jun 1, 1997
Sygnis Bioscience GmbH & Co KG— Founded

2000s

Jul 5, 2006
Axaron Bioscience AG— Acquired

2010s

Jun 26, 2017
Expedeon— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Axaron Bioscience AG

Recent trials (3)

NCT00927836Study directorPhase 2May 1, 2009
NCT00927836Study chairPhase 2May 1, 2009
NCT00927836Lead sponsorPhase 2May 1, 2009

Details

Founded: Heidelberg, DE Jun 1, 1997
Last known activity: May 1, 2009